Subphenotypes of mild-to-moderate COPD by factor and cluster analysis of pulmonary function, CT imaging and breathomics in a population-based survey

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 10, Issue 3, 2013, Pages 277-285

  Fens, Niki ^a   Van Rossum, Annelot G J ^a   Zanen, Pieter ^b   Van Ginneken, Bram ^b,c   Van Klaveren, Rob J ^d   Zwinderman, Aeilko H ^a   Sterk, Peter J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Electronic nose.; Exhaled breath analysis; Metabolomics; Phenotyping; Volatile organic compounds

Indexed keywords

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLUSTER ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; ELECTRONIC NOSE; EXPIRED AIR; FACTORIAL ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HEALTH SURVEY; HUMAN; LUNG EMPHYSEMA; LUNG FUNCTION; MALE; MEASUREMENT ACCURACY; METABOLOMICS; MOLECULAR EPIDEMIOLOGY; PHENOTYPE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RESPIRATORY FAILURE; SMOKING; SYMPTOM; THORAX RADIOGRAPHY; VALIDATION PROCESS;

AGED; BREATH TESTS; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SMOKING CESSATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84878498082     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2012.744388     Document Type: Article

References (39)

1. Available from: http: www. goldcopd. org/. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011.
2. Beasley R, Weatherall M, Travers J, Shirtcliff e P. Time to defi ne the disorders of the syndrome of COPD. Lancet 2009 Aug 29; 374(9691):670-672.
3. Wardlaw AJ, Silverman M, Siva R, Pavord ID, Green R. Multidimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy 2005 Oct; 35(10):1254-1262.
4. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010 Sep 1; 182(5):598-604.
5. Shirtcliff e P, Weatherall M, Travers J, Beasley R. Th e multiple dimensions of airways disease: targeting treatment to clinical phenotypes. Curr Opin Pulm Med 2011 Mar; 17(2):72-78.
6. Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, et al. Acute exacerbations of chronic obstructive pulmonary disease: identifi cation of biologic clusters and their biomarkers. Am J Respir Crit Care Med 2011 Sep 15; 184(6):662-671.
7. Bafadhel M, Umar I, Gupta S, Raj JV, Vara DD, Entwisle JJ, et al. Th e role of CT scanning in multidimensional phenotyping of COPD. Chest 2011 Sep; 140(3):634-642.
8. Weatherall M, Shirtcliff e P, Travers J, Beasley R. Use of cluster analysis to defi ne COPD phenotypes. Eur Respir J 2010 Sep; 36(3):472-474.
9. Weatherall M, Travers J, Shirtcliff e PM, Marsh SE, Williams MV, Nowitz MR, et al. Distinct clinical phenotypes of airways disease defi ned by cluster analysis. Eur Respir J 2009 Oct; 34(4):812-818.
10. Cho MH, Washko GR, Hoff mann TJ, Criner GJ, Hoff man EA, Martinez FJ, et al. Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation. Respir Res 2010; 11:30.
11. Burgel PR, Paillasseur JL, Caillaud D, Tillie-Leblond I, Chanez P, Escamilla R, et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J 2010 Sep; 36(3):531-539.
12. Pistolesi M, Camiciottoli G, Paoletti M, Marmai C, Lavorini F, Meoni E, et al. Identifi cation of a predominant COPD phenotype in clinical practice. Respir Med 2008 Mar; 102(3):367-376.
13. Garcia-Aymerich J, Gomez FP, Benet M, Farrero E, Basagana X, Gayete A, et al. Identifi cation and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Th orax 2011 May; 66(5):430-437.
14. Fens N, de Nijs SB, Peters S, Dekker T, Knobel HH, Vink TJ, et al. Exhaled air molecular profi ling in relation to infl ammatory subtype and activity in COPD. Eur Respir J 2011 Dec;38(6):1301-9.
15. Marsh SE, Travers J, Weatherall M, Williams MV, Aldington S, Shirtcliff e PM, et al. Proportional classifi cations of COPD phenotypes. Th orax 2008 Sep; 63(9):761-767.
16. van Iersel CA, de Koning HJ, Draisma G, Mali WP, Scholten ET, Nackaerts K, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007 Feb 15; 120(4):868-874.
17. Fletcher CM, Pride NB. Defi nitions of emphysema, chronic bronchitis, asthma, and airfl ow obstruction: 25 years on from the Ciba symposium. Th orax 1984 Feb; 39(2):81-85.
18. Burney PG, Luczynska C, Chinn S, Jarvis D. Th e European Community Respiratory Health Survey. Eur Respir J 1994 May; 7(5):954-960.
19. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003; 1:13.
20. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005 Aug; 26(2):319-338.
21. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the singlebreath determination of carbon monoxide uptake in the lung. Eur Respir J 2005 Oct; 26(4):720-735.
22. Gietema HA, Schilham AM, van GB, van Klaveren RJ, Lammers JW, Prokop M. Monitoring of smoking-induced emphysema with CT in a lung cancer screening setting: detection of real increase in extent of emphysema. Radiology 2007 Sep; 244(3):890-897.
23. Stoel BC, Stolk J. Optimization and standardization of lung densitometry in the assessment of pulmonary emphysema. Invest Radiol 2004 Nov;39(11):681-688.
24. Dragonieri S, Schot R, Mertens BJ, Le CS, Gauw SA, Spanevello A, et al. An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol 2007 Oct; 120(4):856-862.
25. Fens N, Zwinderman AH, van der Schee MP, de Nijs SB, Dijkers E, Roldaan AC, et al. Exhaled breath profi ling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med 2009 Dec 1; 180(11):1076-1082.
26. Lewis NS. Comparisons between mammalian and artifi cial olfaction based on arrays of carbon black-polymer composite vapor detectors. Acc Chem Res 2004 Sep;37(9):663-672.
27. Röck F, Barsan N, Weimar U. Electronic nose: current status and future trends. Chem Rev 2008 Feb; 108(2):705-725.
28. de Groot JA, Janssen KJ, Zwinderman AH, Bossuyt PM, Reitsma JB, Moons KG. Correcting for partial verifi cation bias: a comparison of methods. Ann Epidemiol 2011 Feb; 21(2):139-148.
29. Marti H, Chavance M. Multiple imputation analysis of casecohort studies. Stat Med 2011 Jun 15; 30(13):1595-1607.
30. Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med 1991 Apr; 10(4):585-598.
31. Bartholomew DJ, Steele F, Moustaki I, Galbraith J. Factor analysis for binary data. In: Chapman, Hall, editors. Th e Analysis and Interpretation of Multivariate Data for Social Scientists. 2002, Chapman and Hall/CRC, London, UK.
32. Tibshirani R, Walther G, Hastie T. Estimating the number of clusters in a data set via the gap statistic. J R Statist Soc B 2001; (63):411-423.
33. Bolshakova N, Azuaje F. Machaon CVE: cluster validation for gene expression data. Bioinformatics 2003 Dec 12; 19(18):2494-2495.
34. Brusco MJ. Clustering binary data in the presence of masking variables. Psychol Meth 2004 Dec; 9(4):510-523.
35. Agusti A, Celli B. Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation. Eur Respir J 2011 Oct; 38(4):749-751.
36. Lapperre TS, Snoeck-Stroband JB, Gosman MM, Stolk J, Sont JK, Jansen DF, et al. Dissociation of lung function and airway infl ammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004 Sep 1; 170(5):499-504.
37. Ibrahim B, Basanta M, Cadden P, Singh D, Douce D, Woodcock A, et al. Non-invasive phenotyping using exhaled volatile organic compounds in asthma. Th orax 2011 Sep; 66(9): 804-9.
38. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Th e STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003 Jan 7; 138(1):W1-12.
39. Travers J, Marsh S, Williams M, Weatherall M, Caldwell B, Shirtcliff e P, et al. External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Th orax 2007 Mar; 62(3):219-223.